By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Onto Innovation's growth prospects hinge on the successful ramp of the Dragonfly G5 platform and maintaining its large HBM backlog. However, the company faces significant risks, including intense competition from larger players like Applied Materials and KLA, customer concentration in the HBM sector, and potential shifts in packaging architecture.
Risk: Customer concentration in HBM and potential shifts in packaging architecture
Opportunity: Successful ramp of the Dragonfly G5 platform
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Onto Innovation powers AI chip production through critical defect inspection and metrology systems.
Dragonfly G5 demand, expanding HBM contracts, record revenue, and rising margins are strengthening Onto’s AI packaging growth despite competitive risks.
Most investors chasing artificial intelligence (AI) hype names right now are focused on big chip names. Few are thinking about the machines that make sure those chips actually work, and that gap in knowledge is exactly where Onto Innovation (NYSE: ONTO) has been compounding for half a decade.
Onto Innovation makes semiconductor process control equipment: inspection, metrology, and lithography tools that chip manufacturers use before, during, and after production to detect defects and verify quality at the nanometer scale. In a world where a single defective layer on an AI accelerator can render a $10,000 chip useless, this is an essential product.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
The company's track record is grounded in numbers. Onto hit full-year revenue of $1.005 billion in 2025 (a record), capping a run of multiyear growth that has pushed shares up more than 220% since 2022. In the company's earnings release for a 52/53‑week fiscal year, the "full year 2025" revenue of about $1.005 billion is defined as covering the twelve months ended Jan. 3, 2026, which is their fiscal year 2025 rather than the strict calendar year 2025.
In the 2026 first quarter (Q1), it reported preliminary revenue of $292 million, above its own guidance range of $275 million to $285 million. Management then set Q2 2026 guidance at $320 million to $330 million -- an 8% increase above prior outlook -- and guided full-year 2026 revenue growth of more than 30%.
CEO Mike Plisinski has been consistent on the thesis for several years: Onto is not a generic equipment maker riding a broad semiconductor cycle. It is concentrated in the high-growth segments, advanced packaging, high-bandwidth memory, and advanced nodes, which are disproportionately tied to AI infrastructure spending.That positioning is a deliberate product strategy that is now translating into backlog.
Onto's Dragonfly inspection platform is the core of the AI story. In Q4 2025, the company closed a volume purchase agreement worth more than $240 million with a leading high-bandwidth memory (HBM) manufacturer for Dragonfly 2D inspection and 3D bump metrology, running through 2027 -- a contracted revenue line that already locks in a portion of the near-term growth case.
In May 2026, the company disclosed that the next-generation Dragonfly G5, designed for 2.5D advanced AI packaging, had completed customer qualification and would ship its first units in June 2026. Management expects total Dragonfly platform demand to grow more than 50% in 2026 compared with 2025. That product ramp matters because it targets 2.5D packaging, the architecture that stitches together multiple chiplets.
Every AI cluster built around chiplet-based designs needs inspection tools capable of handling the complexity of multi-die packaging. Dragonfly G5 is built for that job, and it is just entering commercial production. Industry analysts estimate that demand for AI-specific advanced packaging inspection will grow over the next few years, and Onto is the leading independent vendor in that market.
Despite the 85% year-to-date move, the consensus analyst price target sits at roughly $334, against a current price near $277, implying more than 10% additional upside at the mean -- and that target has not yet been fully updated for the raised Q2 guidance or the Dragonfly G5 qualification. The company also reached its Q4 2025 operating cash-flow target ahead of schedule and is targeting a Q4 2026 operating margin above 30% -- a level that would represent meaningful expansion from today's margins.
It's important to note that Onto's customer concentration is a material risk. A large portion of its HBM revenue runs through a small number of manufacturers, and if HBM spending cools -- either from oversupply or a slowdown in AI training workloads -- order volumes could fall faster than the backlog suggests. The equipment cycle is also inherently lumpy: Onto missed its Q4 2025 EPS estimate, and a single quarter of order timing shifts can send the stock down sharply even when the long-term trajectory is intact.
Applied Materials and KLA compete across overlapping segments with deeper resources, and both are investing in advanced packaging inspection capabilities that could erode Onto's positioning over time. But Onto's structural setup is hard to argue with.
Onto Innovation has compounded for five years by doing the unglamorous work of making sure AI chips actually function. The Dragonfly G5 ramp, the $240 million HBM purchase agreement, and the 30%-plus revenue growth guidance for 2026 suggest that work is accelerating.
Before you buy stock in Onto Innovation, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Onto Innovation wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $468,861! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,445,212!
Now, it’s worth noting Stock Advisor’s total average return is 1,013% — a market-crushing outperformance compared to 210% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of May 15, 2026. *
Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Applied Materials. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"While Onto’s G5 platform is a critical enabler for advanced packaging, its valuation is currently discounting significant execution success while underestimating the risk of competitive encroachment from larger incumbents like KLA."
Onto Innovation is effectively a 'picks and shovels' play on the complexity of 2.5D and 3D packaging. With 30% revenue growth guidance and the G5 platform ramp, the valuation looks reasonable if they hit that 30% operating margin target by Q4 2026. However, the market is pricing this as a secular winner while ignoring the cyclicality of semiconductor capital intensity. If HBM capacity reaches an equilibrium point or if major foundries like TSMC pivot toward internalizing more metrology processes, Onto’s 'independent vendor' moat could shrink rapidly. The stock is currently priced for perfection, leaving zero room for the inevitable 'lumpy' order delays that historically plague this sub-sector.
Onto’s reliance on a concentrated customer base for HBM makes them highly vulnerable to a single major client’s inventory correction or a shift in packaging standards that renders their current inspection tools obsolete.
"N/A"
[Unavailable]
"Onto has genuine secular tailwinds, but at current valuation the stock has already priced in most of the Dragonfly G5 ramp and assumes no margin compression from competitive pressure or HBM demand normalization."
Onto Innovation's structural positioning in AI packaging inspection is real—the $240M HBM contract and Dragonfly G5 qualification matter. But the article conflates two separate things: (1) secular tailwinds in advanced packaging, which are genuine, and (2) Onto's ability to capture durable margin expansion, which is less certain. At $277 with 30%+ growth guidance, the stock is priced for near-perfect execution. The bigger risk: Applied Materials and KLA aren't sleeping. They have 10x Onto's R&D budgets, existing customer relationships, and can bundle packaging inspection into broader fab solutions. Onto's 85% YTD move already prices in much of the Dragonfly ramp. Customer concentration in HBM (Samsung, SK Hynix, Micron) is a real cliff risk if AI capex normalizes.
If Dragonfly G5 adoption accelerates faster than consensus and HBM demand remains robust through 2027, Onto could sustain 25%+ CAGR and re-rate to 18–20x forward earnings, justifying $380+. The article undersells how hard it is for AMAT/KLA to retrofit packaging inspection into their legacy platforms.
"Onto's upside hinges on a fragile, concentration-heavy AI-packaging cycle that could break if a key customer slows or if competitors erode pricing power."
Onto's story hinges on Dragonfly G5 ramp and a large HBM backlog, but the bull case may be overstated. Revenue is concentrated among a few HBM customers, and Dragonfly deployment is still lumpy—any delay or weaker AI packaging demand could sap near-term growth. Competitors like Applied Materials and KLA can erode pricing/pore into the space as they scale their own advanced packaging inspection. A 2026 >30% margin target depends on sustained backlog conversion and capex cycles that may soften. Valuation already reflects a strong run; the risk-reward looks more balanced if AI spending cools or a key customer throttles orders.
The strongest countercase: Onto's growth is front-loaded in a few customers and the Dragonfly ramp is unproven at scale; any hiccup could send orders and margins sharply lower, and peers could replicate/offset the advantage.
"Onto's agility in specialized metrology provides a structural advantage over larger incumbents that outweighs their R&D budget disparity."
Claude, you’re underestimating the 'moat' of specialized metrology. KLA and AMAT are behemoths, but their bulk makes them slow to adapt to the specific, high-aspect-ratio inspection requirements of 3D-stacked HBM. Onto’s agility isn't just about R&D spend; it's about being the 'pure play' that doesn't force clients into an ecosystem lock-in. The real risk isn't competition—it's the potential for a sudden shift in packaging architecture, like a move toward hybrid bonding, which could render current inspection methodologies obsolete.
[Unavailable]
"Specialized agility doesn't survive when competitors have 10x your scale and existing customer lock-in; Onto's valuation leaves no margin for error on HBM demand."
Gemini's 'pure-play agility' argument doesn't hold up under scrutiny. KLA and AMAT have already shipped packaging inspection tools; they're not starting from zero. The real moat question: can Onto defend pricing when AMAT bundles inspection into their $50M+ fab solutions? Onto's 85% YTD run already prices in Dragonfly success. The cliff risk Claude flagged—customer concentration in HBM—is underweighted here. One Samsung inventory correction and margins crater.
"Dragonfly ramp timing and AI packaging demand are the real margin risk, not just HBM customer concentration."
Responding to Claude: I agree AMAT/KLA pose a bundle risk, but the bigger flaw is assuming margins hold if Dragonfly ramps—growth is still lumpy and highly back-end loaded. A Samsung inventory wobble or a slower AI capex cycle could snap orders, yet Dragonfly’s ramp may act as a stair-step, not a straight line, pressuring margins well before the 30% target by 2026. Bearish near-term, contingent on Dragonfly visibility.
Onto Innovation's growth prospects hinge on the successful ramp of the Dragonfly G5 platform and maintaining its large HBM backlog. However, the company faces significant risks, including intense competition from larger players like Applied Materials and KLA, customer concentration in the HBM sector, and potential shifts in packaging architecture.
Successful ramp of the Dragonfly G5 platform
Customer concentration in HBM and potential shifts in packaging architecture